| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 697235-49-7 | Hydroxyphenyl propamidobenzoic acid;2-((3-(4-Hydroxyphenyl)-1-oxopropyl)amino)benzoic acid; Dihydroavenanthramide D; Symcalmin | C16H15NO4 |
| 697299-87-9 | tert-Butyl (4-bromothiazol-2-yl)methylcarbamate | C9H13BrN2O2S |
| 697300-68-8 | 6-Bromo-5-iodo-3-pyridinamine | C5H4BrIN2 |
| 697300-73-5 | 3-Bromo-5-iodo-2-pyridinamine | C5H4BrIN2 |
| 697306-45-9 | 1-Phenyl-4-piperidinemethanol | C12H17NO |
| 697739-03-0 | 5-Fluoro-2-methyl-3-nitrobenzoic acid methyl ester;Methyl 5-fluoro-2-methyl-3-nitrobenzoate | C9H8FNO4 |
| 697739-05-2 | Methyl 6-fluoro-1H-indazole-4-carboxylate | C9H7FN2O2 |
| 697739-13-2 | Imidazo(1,5-a)pyridine-8-carboxylic acid | C8H6N2O2 |
| 697739-22-3 | 2-Chloro-6-methylpyridine-4-boronic acid, pinacol ester | C12H17BClNO2 |
| 697739-24-5 | 2-Chloro-6-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | C12H17BClNO3 |
| 697739-42-7 | {2-[(4-Oxo-1-piperidinyl)methyl]phenyl}boronic acid | C12H16BNO3 |
| 697761-98-1 | Elvitegravir;GS 9137; JTK 303; 6-(3-Chloro-2-fluorobenzyl)-1-(1(S)-(hydroxymethyl)-2-methylpropyl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | C23H23ClFNO5 |
| 697762-60-0 | 7-Fluoro-1,4-dihydro-1-((1S)-1-(hydroxymethyl)-2-methylpropyl)-6-iodo-4-oxo-3-quinolinecarboxylic acid ethyl ester | C17H19FINO4 |
| 698355-80-5 | (4-Bromophenyl)(1,3-oxazol-2-yl)methanone | C10H6BrNO2 |
| 698359-01-2 | 4-Ethyl-2-[4-Ethyl-5-[(Phenylmethyl)Thio]-1,3-Dithiol-2-Ylidene]-5-[(Phenylmethyl)Thio]-1,3-Dithiole | C24H24S6 |
| 698378-81-3 | Ethyl 2,2-difluoro-2-(3-fluorophenyl)acetate | |
| 698387-09-6 | Neratinib;(2E)-N-(4-((3-chloro-4-((pyridin-2-yl)methoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide; HKI-272 | C30H29ClN6O3 |
| 698392-47-1 | Ethyl (2,6-dimethylphenyl)(oxo)acetate | C12H14O3 |
| 698393-07-6 | 3,5-Dibromo-4-chloro-2-pyridinecarboxylic acid | C6H2Br2ClNO2 |
| 698394-60-4 | 2-Bromo-1-(4-ethylphenyl)-2-methylpropan-1-one | C12H15BrO |
| 698394-73-9 | Vercirnon;N-(4-Chloro-2-((1-oxido-4-pyridinyl)carbonyl)phenyl)-4-(1,1-dimethylethyl)benzenesulfonamide; GSK 1605786 | C22H21ClN2O4S |
| 698970-84-2 | (3-Bromo-2-pyridinyl)acetic acid | C7H6BrNO2 |
| 698988-07-7 | 4-Amino-N-(4-fluorophenyl)benzamide | C13H11FN2O |
| 698992-37-9 | 3-(4-Aminophenyl)-N-cyclopropylpropanamide | C12H16N2O |
| 698999-09-6 | 5'-Chloro-5'-deoxyadenosine hydrate (1:1) | C10H14ClN5O4 |
| 698999-22-3 | 2,4-Dinitrobenzenesulfonic acid hydrate | |
| 698999-57-4 | Manganese-perchloric acid hydrate (1:1:1) | H3ClMnO5 |
| 698999-65-4 | Cerium(4+) tetrakis(trifluoromethanesulfonate) | C4CeF12O12S4 |
| 698999-85-8 | beta-Nicotinamide adenine dinucleotide phosphate sodium salt hydrate | C21H29N7NaO17P3 |
| 699012-88-9 | Tris[(3Z)-4-(hydroxy-kappaO)-3-penten-2-onato]scandium hydrate (1:1) | C15H23O7Sc |
| 699012-94-7 | Sodium tetrakis(cyano-kappaC)platinate(2-) hydrate (2:1:1) | C4H2N4Na2OPt |
| 699014-53-4 | Bis(D-gluconato-kappaO1)iron hydrate (1:1) | C12H24FeO15 |
| 699016-24-5 | 3-Fluoro-5-methoxybenzaldehyde;5-Fluoro-3-methoxybenzaldehyde | C8H7FO2 |
| 699016-40-5 | 2-Fluoro-4-iodobenzaldehyde | C7H4FIO |
| 699020-02-5 | alpha-Cyclodextrin hydrate sulfate sodium salt;alpha-Cyclodextrin hydrogen sulfate sodium salt hydrate | C36H60O30.x(H2O4S).x(H2O).xNa |
| 699119-05-6 | 1-Bromo-4-iodo-2,5-dimethylbenzene | C8H8BrI |
| 700362-32-9 | 2,2,2-Trifluoro-1-(2-nitrophenyl)ethanol | C8H6F3NO3 |
| 700381-18-6 | 2-Methoxy-5-fluorobenzylbromide;2-Bromomethyl-4-fluoro-1-methoxybenzene | C8H8BrFO |
| 700797-68-8 | 2-(Cyclopentylamino)cyclopentanecarboxylic acid | C11H19NO2 |
| 700811-29-6 | 2-Chloro-4-hydrazinopyridine | C5H6ClN3 |
| 700815-60-7 | 1-(Cyclobutylcarbonyl)-4-piperidinecarboxylic acid | C11H17NO3 |
| 700834-18-0 | 4-(Formylamino)-3-Methoxy-Benzoic Acid Methyl Ester | C10H11NO4 |
| 700844-09-3 | 7-Chlorothieno(3,2-b)pyridine-6-carbonitrile | C8H3ClN2S |
| 700844-17-3 | 7-Chloro-2-iodothieno(3,2-b)pyridine-6-carbonitrile | C8H2ClIN2S |
| 700863-30-5 | trans-2-(4-Bromophenyl)-5-propyltetrahydro-2H-pyran | C14H19BrO |
| 700871-88-1 | 4,7-Dibromoquinoline | C9H5Br2N |
| 700874-71-1 | LY 2109761;4-(5,6-Dihydro-2-(2-pyridinyl)-4H-pyrrolo(1,2-b)pyrazol-3-yl)-7-(2-(4-morpholinyl)ethoxy)quinoline | C26H27N5O2 |
| 700874-72-2 | LY 2157299;4-(5,6-Dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo(1,2-b)pyrazol-3-yl)-6-quinolinecarboxamide | C22H19N5O |
| 701213-36-7 | BMS 626529;1-Benzoyl-4-((4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo(2,3-c)pyridin-3-yl)oxoacetyl)piperazine | C24H23N7O4 |
| 701220-40-8 | 1-[4-(4-Amino-2-chlorophenyl)-1-piperazinyl]-2-methyl-1-propanone | C14H20ClN3O |